LncTUG1 contributes to the progression of hepatocellular carcinoma via the miR-144-3p/RRAGD axis and mTOR/S6K pathway
Abstract Hepatocellular carcinoma (HCC) is a symptomatic disease involed multi-stage program. Here, we elucidated the molecular mechanism of LncTUG1 in the regulation of HCC evolvement. And that may in all likelyhood supply a innovative latent target for HCC’s diagnoses and prognosis. LncRNA TUG1, m...
Main Authors: | Weixi Chen, Zekun Bai, Wen Bai, Wei Wang, Jiapei Guo, Mengnan Guo, Yingying Sai, Jun Shi, Jinghua Wu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-05-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-33976-5 |
Similar Items
-
The regulatory role and mechanism of lncTUG1 on cartilage apoptosis and inflammation in osteoarthritis
by: Nan-nan Liu, et al.
Published: (2023-06-01) -
Epigenetic Regulation of Hepatocellular Carcinoma Progression through the mTOR Signaling Pathway
by: Mengnan Guo, et al.
Published: (2021-01-01) -
LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
by: Rongshou Wu, et al.
Published: (2023-10-01) -
LncTUG1 ameliorates renal tubular fibrosis in experimental diabetic nephropathy through the miR-145-5p/dual-specificity phosphatase 6 axis
by: Taoxia Wang, et al.
Published: (2023-12-01) -
RRAGD-associated autosomal dominant kidney hypomagnesemia with cardiomyopathy (ADKH-RRAGD): a review on the clinical manifestations and therapeutic options
by: Francesco Trepiccione, et al.
Published: (2024-06-01)